Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: Insight into the mechanism of retinoid action in psoriasis

Cell Growth and Differentiation

Volumn 7, Issue 12, 1996, Pages 1783-1791

  Nagpal, Sunil ^a   Thacher, Scott M ^a   Patel, Sheetal ^a   Friant, Sylvie ^a   Malhotra, Monica ^a   Shafer, Jonathan ^a   Krasinski, Glenn ^a   Asano, Arisa T ^b   Teng, Min ^a   Duvic, Madeleine ^b   Chandraratna, Roshantha A S ^a  

^a ALLERGAN INC   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; GAMMA INTERFERON; HYDROCORTISONE; MIGRATION INHIBITION FACTOR; PLACEBO; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEINASE; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; TAZAROTENE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; PUNCH BIOPSY; TOPICAL DRUG ADMINISTRATION;

ANTIGENS, DIFFERENTIATION; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CALGRANULIN A; CELL DIFFERENTIATION; CELLS, CULTURED; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOGEN DEBRANCHING ENZYME SYSTEM; HUMANS; INTERFERON TYPE II; KERATINOCYTES; MALE; NICOTINIC ACIDS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; PSORIASIS; RECEPTORS, RETINOIC ACID; RETINOIDS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SERINE PROTEINASE INHIBITORS; SKIN; TERATOGENS;

EID: 10544244166     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Chambon, P. The retinoid signalling pathways: molecular and genetic analyses. Semin. Cell Biol., 5: 115-125, 1994.
2. Boehm, M. F., Heyman, R. A., Patel, S., Stein, R. B., and Nagpal, S. Retinoids: biological function and use in the treatment of dermatological diseases. Exp. Opin. Invest. Drugs, 4: 593-612, 1995.
3. Nagpal, S., Athanikar, J., and Chandraratna, R. A. S. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α. J. Biol. Chem., 270: 923-927, 1995.
4. Esgleyes-Ribot, T., Chandraratna, R. A., Lew-Kaya, D. A., Sefton, J., and Duvic, M. Response of psoriasis to a new topical retinoid, AGN 190168. J. Am. Acad. Dermatol., 30: 581-590, 1994.
5. Weinstein, G., Jeffes, E., Duvic, M., Freidman, D., Jegasothy, B., Tharp, M., Jorizzo, J., Krueger, G., Lowe, N., Shmunes, E., Tschen, E., Monroe, A., Sefton, J., Lew-Kaya, D., Lue, J., Chandraratna, R., and Gibson, J. Tazarotene gel for the treatment of plaque psoriasis: a double-blind clinical study. J. Invest. Dermatol., 15: 104, 1995.
6. Gottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., and Krueger, J. G. Response of psoriasis to a lymphocyte-selective toxin (DAB389 IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat. Med., 1: 442-447, 1995.
7. Lowe, N. J., Kaplan, R., and Breeding, J. Etretinate treatment for psoriasis inhibits epidermal ornithine decarboxylase. J. Am. Acad. Dermatol., 6: 697-698, 1982.
8. Nagpal, S., Patel, S., Asano, A. T., Johnson, A. T., Duvic, M., and Chandraratna, R. A. S. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J. Invest. Dermatol., 106: 269-274, 1996.
9. Odink, K., Cerletti, N., Bruggen, J., Clerc, R. G., Tarcsay, L., Zwadelo, G., Gerhards, G., Schlegel, R., and Sorg, C. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature (Lond.), 330: 80-82, 1987.
10. Saheki, T., Ito, F., Hagiwara, H., Saito, Y., Kuroki, J., Tachibana, S., and Hirose, S. Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment. Biochem. Biophys. Res. Commun., 185: 240-245, 1992.
11. Mothuizen, H. O. F., Alkemade, H. A. C., Zeeuwen, P. L. J. M., de Jongh, G. J., Wieringa, B., and Schalkwijk, J. SKALP/Elafin: an elastase inhibitor from cultured human keratinocytes J. Biol. Chem., 268: 12028-12032, 1993.
12. Madsen, P., Rasmussen, H. H., Letters, H., Honoré, B., and Celis, J. E. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly upregulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J. Invest. Dermatol., 99: 299-305, 1992.
13. Lehmann, J. M., Jong, L., Fanjul, A., Cameron, J. F., Lu, X. P., Haefner, P., Dawson, M. I., and Pfahl, M. Retinoids selective for retinoid X receptor response pathways. Science (Washington DC), 258: 1944-1946, 1992.
14. Fisher, G. J., Talwar, H. S., Xiao, J-H., Datta, S. C., Reddy, A. P., Gaub, M-P., Rochette-Egly, C., Chambon. P., and Voorhees, J. J. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J. Biol. Chem., 269: 20629-20635, 1994.
15. Kelly, S. E., Jones, D. B., and Fleming, S. Calgranulin expression in inflammatory dermatoses. J. Pathol., 159: 17-21, 1989.
16. Saunders, N. A., and Jetten, A. M. Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon-γ: antagonism by retinoic acid and transforming growth factor β1. J. Biol. Chem., 269: 2016-2022, 1994.
17. Nonomura, K., Yamanishi, K., Hosokawa, Y., Doi, H., Hirano, J., Fukushima, S., and Yassuno, H. Localization of transglutaminase I mRNA in normal and psoriatic epidermis by non-radioactive in situ hybridization. Br. J. Dermatol., 128: 23-28, 1993.
18. Thacher, S. M., and Rice, R. H. Keratinocyte-specific transglutaminase of cultured epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell, 40: 685-695, 1985.
19. Wilkinson, M. M., Busuttil, A., Hayward, C., Brock, D. J. H., Dorin, L. R., and van Heyningen, V. Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J. Cell Sci., 91: 221-230, 1988.
20. Schalkwijk, J., van Vlijmen, I. M. J. J., Alkemade, J. A. C., and de Jongh, G. J. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis. J. Invest. Dermatol., 100: 390-393, 1993.
21. Barthe, C., Figarella, C., Carrere, J., and Guy-Crotte, O. Identification of cystic fibrosis protein as a complex of two calcium-binding proteins present in human cells of myeloid origin. Biochim. Biophys. Acta, 1096: 175-177, 1991.
22. Hessian, P. A., Edgeworth, J., and Hogg, N. MRP-8 and MRP-14: two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J. Leukocyte Biol., 53: 197-204, 1993.
23. Clark, B. B., Kelly, S. E., and Fleming, S. Calgranulin expression and association with keratinocyte cytoskeleton. J. Pathol., 160: 25-30, 1990.
24. Lackmann, M., Rajasekariah, P., Iismaa, S. E., Jones, G., Cornish, C. J., Hu, S., Simpson, R. J., Moritz, R. L., and Geczy, C. L. Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. J. Immunol., 150: 2981-2991, 1993.
25. Dover, R., and Watt, F. M. Measurement of the rate of epidermal terminal differentiation: expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques. J. Invest. Dermatol., 89: 349-352, 1987.
26. Hohl, D., de Viragh, P. A., Amiguet-Barras, F., Gibbs, S., Backendorf, C., and Huber, M. The small proline-rich proteins constitute a multigene family of differentially regulated cornified cell envelope precursor proteins. J. Invest. Dermatol., 104: 902-909, 1995.
27. Takahashi, M., Tezuka, T., and Katunuma, N. Phosphorylated cystatin α is a natural substrate of epidermal transglutaminase for formation of skin cornified envelope. FEBS Lett., 308: 79-82, 1992.
28. Hohl, D., Mehrel, T., Lichti, U., Turner, M. L., Roop, D. R., and Steinert, P. M. Characterization of human loricrin. J. Biol. Chem., 266: 6626-6636, 1991.
29. Schafer, B. W., Wicki, R., Engelkamp, D., Mattei, M-G., and Heizmann, C. W. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics, 25: 638-643, 1995.
30. Steinert, P. M., and Marekov, L. N. The proteins elafin, filaggrin. keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J. Biol. Chem., 270: 17702-17711, 1995.
31. Schmid, P., Itin, P., Cox, D., McMaster, G. K., and Horisberger, M. A. The type I Interferon system is locally activated in psoriatic lesions. J. Interferon Res., 14: 229-234, 1994.
32. Gendimenico, G. J., Stim, T. B., Corbo, M., Janssen, B., and Mezick, J. A. A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by all-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selective agonist. J. Invest. Dermatol., 102: 676-680, 1994.
33. Saunders, N. A., Bernacki, S. H., Volberg, T. M., and Jetten, A. M. Regulation of transglutaminase type I expression in squamous differentiating rabbit tracheal epithelial cells and human epidermal keratinocytes: effects of retinoic acid and phorbol esters. Mol. Endocrinol., 7: 387-398, 1993.
34. Weiss, R. A., Eichner, R., and Sun, T. T. Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kilodalton keratin as molecular markers for hyperproliferative keratinocytes. J. Cell Biol., 98: 1397-1406, 1984.
35. Alkemade, J. A. C., Molhuizen, H. O. F., Ponec, M., Kempenaar, J. A., Zeeuwen, P. L. J. M., de Jongh, G. J., van Vlijman-Willems, I. M. J. J., van Erp, P. E. J., van de Kerkhof, P. C. M., and Schalkwijk, J. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J. Cell Sci., 107: 2335-2342, 1994.
36. Mansbridge, J. N., and Knapp, A. M. Changes in keratinocyte maturation during wound healing. J. Invest. Dermatol., 89: 253-263, 1987.
37. Saintigny, G., Schmidt, R., Shroot, B., Juhlin, L., Reichert, U., and Michel, S. Differential expression of calgranulin A and B in various epithelial cell lines and reconstructed epidermis. J. Invest. Dermatol., 99: 639-644, 1992.
38. Griffiths, C. E. M., Elder, J. T., Bernard, B. A., Rossio, P., Cromie, M. A., Finkel, L. J., Shroot, B., and Voorhees, J. J. Comparison of CD271 (Adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J. Invest. Dermatol., 101: 325-328, 1993.
39. Griffiths, C. E. M., Rosenthal, D. S., Reddy, A. P., Elder, J. T., Astrom, A., Leach, K., Wang, T. S., Finkel, L. J., Yuspa, S. H., Voorhees, J. J., and Fisher, G. J. Short-term retinoic acid treatment increases in vivo, but decreases in vitro, epidermal transglutaminase-K activity and immunoreactivity. J. Invest. Dermatol., 99: 283-288, 1992.
40. Connor, M. J., Ashton, R. E., and Lowe, N. J. A comparative study of the induction of epidermal hyperplasia by natural and synthetic retinoids. J. Pharmacol. Exp. Ther., 237: 31-35, 1986.
41. Allegretto, E. A., McClurg, M. R., Lazarchik, S. B., Clemm, D. L., Kerner, S. A., Elgort, M. G., Boehm, M. F., White, S. K., Pike, J. W., and Heyman, R. A. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. J. Biol. Chem., 268: 26625-26633, 1993.
42. Haendler, B., Hofer-Warbinek, R., and Hofer, E. Complementary DNA for human T-cell cyclophilin. EMBO J., 6: 947-950, 1987.